Red Blood Cell Distribution Width as Novel Biomarker in Cardiovascular Diseases: A Literature Review
Mesay Arkew,Kabtamu Gemechu,Kassahun Haile,Haftu Asmerom
DOI: https://doi.org/10.2147/JBM.S367660
2022-08-02
Journal of Blood Medicine
Abstract:Mesay Arkew, 1 Kabtamu Gemechu, 1 Kassahun Haile, 2 Haftu Asmerom 1 1 School of Medical Laboratory Sciences, College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia; 2 Department of Medical Laboratory Science, College of Medicine and Health Sciences, Wolkite University, Wolkite, Ethiopia Correspondence: Mesay Arkew, School of Medical Laboratory Sciences, College of Health and Medical Sciences, Haramaya University, P.O. Box: 235, Harar, Ethiopia, Email Red blood cell distribution width (RDW) is a measure of the change in size of red blood cells and it is used in combination with other hematological parameters for the differential diagnosis of anemias. Recent evidence suggested that the change in RDW level may be a predictive biomarker of morbidity and mortality in cardiovascular diseases (CVDs). Cardiovascular diseases are the most common cause of death globally as compared to cancer and communicable diseases. Early diagnosis and prompt intervention of these diseases are very important to minimize their complications. Nowadays, the diagnosis of most cardiovascular diseases majorly depends on clinical judgment, electrocardiography and biochemical parameters. Red blood cell distribution width as a new predictive biomarker may play a pivotal role in assessing the severity and progression of CVDs. However, the underlying mechanisms for the association between RDW and CVDs are not clear. A deeper understanding of their association could help the physicians in more careful identification, early prevention, intervention, and treatment to prevent adverse cardiovascular events. This review aims to elaborate on the recent knowledge on the association between RDW and cardiovascular diseases and some possible pathophysiological mechanisms. Keywords: biomarkers, cardiovascular diseases, inflammation, red blood cell distribution width, prognosis Red blood cells (RBCs) are non-nucleated blood cells characterized by having a typical oval biconcave shape, with a diameter of 6 to 8 μm and a thickness of 2 μm. The normal volume of RBCs ranges from 80 to 100 femtoliter (fL), but different physiological and pathological conditions may increase the degree of anisocytosis. The red blood cell distribution width (RDW) is a quantitative measure of variation in the size of circulating RBCs, which is receiving increasing interest as a diagnostic and prognostic marker in a vast array of human disorders. 1 The RDW has been introduced as a novel inflammatory predictor in various disorders including functional bowel conditions, 2 autoimmune diseases, 3,4 malignancy, 5 COVID-19 and multiple hospital admissions in subjects with chronic conditions. 6 Red blood cell distribution width is calculated automatically by hematological analyzers by simply dividing the standard deviation (SD) of the mean corpuscular volume (MCV) by the MCV and multiplying by 100 to yield a percentage value. Since the methods of measuring the RBC size, the instrument, and statistical methods are varying in many laboratories, there is no established common reference range till now. 7 The normal reference range of RDW most laboratories used is roughly ranging from 11% to 15%. An RDW value below the reference range has been considered without clinical relevance, whereas an increased RDW value reflects a greater difference in the size of RBCs, which can be due to the presence of smaller or larger RBCs, or both. An elevated RDW usually results from increased or ineffective production of RBCs and excessive fragmentation or destruction of RBCs. 8 Thus, RDW is increased in patients with iron deficiency anemia, megaloblastic anemia, myelodysplastic syndrome, hemolytic anemia, liver failure, sickle cell disease, and blood transfusions. 9 Red blood cell distribution width together with MCV has been almost exclusively used for the differential diagnosis of anemias. 1 However, it is almost an unknown parameter to which very few clinicians pay attention when examining blood cell count. In addition to RBC disorders, various cardiovascular diseases (CVDs) such as heart failure (HF), ischemic cerebrovascular disease (including stroke), acute coronary syndrome (ACS), peripheral artery disease (PAD), hypertension, and atrial fibrillation (AF) are often associated with a high degree of anisocytosis. 10 Since both RDW and cardiovascular conditions are associated with inflammation, RDW could also be associated with CV diseases. Cardiovascular diseases are a diverse group of disorders that affect the heart and blood vessels, and they are mostly interrelated with the underlying pathology of atherosclerosis. 11 Compared to cancer and communicable diseases, CVD continues to be the most common cause -Abstract Truncated-